CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 66 enrolled
Drug / intervention
BenzaClin +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01237821
NCT01237821N/ACompleted
CompareCT.gov

A MULTI-CENTER, DOUBLE-BLIND CLINICAL TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF TWO ACNE CREAMS IN SUBJECTS WITH MILD TO MODERATE ACNE VULGARIS

Milton S. Hershey Medical Center·interventional·Posted Nov 10, 2010·Updated Jul 16, 2019

In Brief

A clinical study evaluating BenzaClin and Effaclar for Acne Vulgaris. Completed, enrolled 66 participants across 1 site.

Detailed Summary

This research is being done to find out the safety and efficacy of two acne creams, Effaclar and Benzaclin when used twice daily with a topical retinoid. Effaclar and Benzaclin are FDA approved for the treatment of acne.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcne Vulgaris
CountriesUnited States
CollaboratorsLoreal USA

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedNov 10, 2010
Enrollment StartOct 1, 2010
Primary CompletionAug 1, 2011
Study CompletionOct 1, 2011
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 15.6 years ago

Interventions

BenzaClindrug

Topical, 1% Clindamycin/5% Benzoyl Peroxide, BID, 12 weeks

Effaclardrug

Topical, Bid, 12 weeks